21 March 2024
21 March 2024
Lilly says that the FDA wants to look closer at efficacy implications of the Phase III donanemab trial design before giving the green light.
The US Food and Drug Administration’s (FDA) Peter Marks discussed how collaborative initiatives with other agencies could aid the review of gene therapy applications.
At the Advanced Therapies Conference 2024, experts explained the key priorities for early-stage biotechs in finding investment.
The past, current, and future efforts in treating cancer were discussed on day one of ELRIG UK conference in Manchester, UK.
Panellists discuss opportunities and challenges in cell and gene therapies at the Advanced Therapies conference in London, UK.
Biotech executives discuss why developing gene therapies for central nervous system disorders remains difficult at a recent conference.
Forbion general partner Nanna Luneborg will join the board of directors of the company.
The 43,000m² Daejeon site will supply critical biotech products for biopharma companies.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
